Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miroslav Backonja

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Pain Medicine (Malden, Mass.)|June 16, 2010
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded studyVladimir Skljarevski, Shuyu Zhang, Amy S Chappell, et al.
CNS Drugs|November 17, 2016
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewRainer Freynhagen, Miroslav Backonja, Stephan Schug, et al.
Diabetes & Vascular Disease Research|October 25, 2006
New perspectives on the management of diabetic peripheral neuropathic painTroels S Jensen, Misha-Miroslav Backonja, Sergio Hernández Jiménez, et al.
Pain|January 16, 2002
Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome?Stephen Bruehl, R Norman Harden, Bradley S Galer, et al.
The Journal of Pain|March 5, 2008
Voluntary facial displays of pain increase suffering in response to nociceptive stimulationTim V Salomons, James A Coan, S Matthew Hunt, et al.
Neurology|August 8, 2007
Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyWilliam M Landau, Dewey A Nelson, Carmel Armon, et al.
The Clinical Journal of Pain|July 15, 2011
NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgiaGordon A Irving, Miroslav Backonja, Richard Rauck, et al.
Journal of Pain Research|May 13, 2021
Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and AttitudesJan M Schilling, Chloe G Hughes, Mark S Wallace, et al.
The Lancet. Neurology|November 4, 2008
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyMiroslav Backonja, Mark S Wallace, E Richard Blonsky, et al.
Pain Practice : the Official Journal of World Institute of Pain|December 7, 2006
Quantitative sensory testing for spinal cord stimulation in patients with chronic neuropathic painElon Eisenberg, Misha-Miroslav Backonja, Roger B Fillingim, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Pain Medicine (Malden, Mass.)|June 16, 2010
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded studyVladimir Skljarevski, Shuyu Zhang, Amy S Chappell, et al.
CNS Drugs|November 17, 2016
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewRainer Freynhagen, Miroslav Backonja, Stephan Schug, et al.
Diabetes & Vascular Disease Research|October 25, 2006
New perspectives on the management of diabetic peripheral neuropathic painTroels S Jensen, Misha-Miroslav Backonja, Sergio Hernández Jiménez, et al.
Pain|January 16, 2002
Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome?Stephen Bruehl, R Norman Harden, Bradley S Galer, et al.
The Journal of Pain|March 5, 2008
Voluntary facial displays of pain increase suffering in response to nociceptive stimulationTim V Salomons, James A Coan, S Matthew Hunt, et al.
Neurology|August 8, 2007
Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyWilliam M Landau, Dewey A Nelson, Carmel Armon, et al.
The Clinical Journal of Pain|July 15, 2011
NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgiaGordon A Irving, Miroslav Backonja, Richard Rauck, et al.
Journal of Pain Research|May 13, 2021
Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and AttitudesJan M Schilling, Chloe G Hughes, Mark S Wallace, et al.
The Lancet. Neurology|November 4, 2008
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyMiroslav Backonja, Mark S Wallace, E Richard Blonsky, et al.
Pain Practice : the Official Journal of World Institute of Pain|December 7, 2006
Quantitative sensory testing for spinal cord stimulation in patients with chronic neuropathic painElon Eisenberg, Misha-Miroslav Backonja, Roger B Fillingim, et al.
Pageof 8